Adaptation to chronic mTOR inhibition in cancer and in aging.
about
Inhibition of mTORC1 Enhances the Translation of Chikungunya Proteins via the Activation of the MnK/eIF4E PathwaySelective anti-cancer agents as anti-aging drugsMetabolic control of tumour progression and antitumour immunityMitochondrial function and mitochondrial DNA maintenance with advancing age.Dual abrogation of MNK and mTOR: a novel therapeutic approach for the treatment of aggressive cancers.Combined therapy with RAD001 e BEZ235 overcomes resistance of PET immortalized cell lines to mTOR inhibition.Cross-communication between histone H3 and H4 acetylation and Akt-mTOR signalling in prostate cancer cells.Enzyme Complexes Important for the Glutamate-Glutamine Cycle.
P2860
Q27318237-90D17B29-D605-4324-9F1D-ACDDBC4442D5Q34392470-54687BF3-FEB3-41A5-802D-B548515B01F2Q38168678-F013253B-7FE1-4775-A5B3-C1F83A823E23Q38228592-2B3E2F90-E837-4A78-BE70-DC2F71D7F6CCQ38637354-FF956DB5-926D-4E53-9DE0-353D1725EC3FQ38975178-ADFE6FEC-4AB8-4DAF-998D-FA73051C86B4Q41874831-57DCC9FD-478F-4AB9-8C70-F7D80BF9BC66Q48417490-3236B01E-D338-43B9-98F9-880479804C08
P2860
Adaptation to chronic mTOR inhibition in cancer and in aging.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Adaptation to chronic mTOR inhibition in cancer and in aging.
@en
type
label
Adaptation to chronic mTOR inhibition in cancer and in aging.
@en
prefLabel
Adaptation to chronic mTOR inhibition in cancer and in aging.
@en
P2093
P2860
P356
P1476
Adaptation to chronic mTOR inhibition in cancer and in aging
@en
P2093
Claire L Cope
Kathryn Balmanno
Rebecca Gilley
P2860
P304
P356
10.1042/BST20130080
P50
P577
2013-08-01T00:00:00Z